文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性冠脉综合征合并阻塞性睡眠呼吸暂停患者夜间低氧血症与较低心血管事件的相关性

Association of Nocturnal Hypoxemia With Lower Cardiovascular Events in Patients With Acute Coronary Syndrome and OSA.
PubMed 文献 · Chest · 2025-12-30
一句话结论在急性冠脉综合征合并阻塞性睡眠呼吸暂停的患者中,中度至重度夜间低氧血症与较低的心血管事件风险相关,此发现需进一步研究。

本研究为两项前瞻性队列研究的汇总回顾性分析,纳入2810例急性冠脉综合征患者,按血氧饱和度低于90%的时间百分比(TSA90)三分位分为轻度、中度和重度夜间低氧血症组。主要终点为1年主要不良心脑血管事件(MACCE)。在合并阻塞性睡眠呼吸暂停的患者中,中度和重度低氧血症组MACCE发生率分别为77.8和72.7/1000人年,低于轻度组的120.0/1000人年(P=0.044);多因素调整后,重度低氧血症与MACCE风险降低50%相关(HR 0.50,95%CI 0.29-0.87,P=0.015),中度低氧血症与全因死亡风险降低79%相关(HR 0.21,95%CI 0.05-0.84,P=0.028)。不合并阻塞性睡眠呼吸暂停的患者中未见显著关联。

要点

  • 在合并阻塞性睡眠呼吸暂停的急性冠脉综合征患者中,重度夜间低氧血症与1年MACCE风险降低50%相关(HR 0.50,95%CI 0.29-0.87,P=0.015)。
  • 合并阻塞性睡眠呼吸暂停的患者中,中度夜间低氧血症与全因死亡风险降低79%相关(HR 0.21,95%CI 0.05-0.84,P=0.028)。
  • 合并阻塞性睡眠呼吸暂停的患者中,中度夜间低氧血症与心血管死亡风险降低84%相关(HR 0.16,95%CI 0.03-0.78,P=0.024)。
  • 不合并阻塞性睡眠呼吸暂停的急性冠脉综合征患者中,各低氧血症三分位组与结局均无显著关联(P均>0.05)。
  • 限制性立方样条分析显示,合并阻塞性睡眠呼吸暂停的患者中TSA90与结局呈U型关系。

适用人群与场景

  • 急性冠脉综合征患者,来自两项前瞻性队列研究的汇总数据,共2810例,其中1408例合并阻塞性睡眠呼吸暂停,1402例不合并。

诊断标准与关键阈值

  • 按血氧饱和度低于90%的时间百分比(TSA90)三分位分为轻度、中度和重度夜间低氧血症组。

研究设计与关键结果

  • 研究类型:两项前瞻性队列研究的汇总回顾性分析,样本量2810例急性冠脉综合征患者,其中合并阻塞性睡眠呼吸暂停1408例,不合并1402例。
  • 主要终点:1年MACCE。合并阻塞性睡眠呼吸暂停患者中,中度低氧血症组77.8/1000人年、重度低氧血症组72.7/1000人年,分别低于轻度低氧血症组的120.0/1000人年(P=0.044)。
  • 多因素调整后,合并阻塞性睡眠呼吸暂停患者中,重度低氧血症与MACCE风险降低50%相关(HR 0.50,95%CI 0.29-0.87,P=0.015),与非致死性心肌梗死风险降低68%相关(HR 0.32,95%CI 0.12-0.86,P=0.023)。
  • 多因素调整后,合并阻塞性睡眠呼吸暂停患者中,中度低氧血症与全因死亡风险降低79%相关(HR 0.21,95%CI 0.05-0.84,P=0.028),与心血管死亡风险降低84%相关(HR 0.16,95%CI 0.03-0.78,P=0.024)。
  • 限制性立方样条分析显示,合并阻塞性睡眠呼吸暂停患者中TSA90与结局呈U型关系。
  • 不合并阻塞性睡眠呼吸暂停患者中,各低氧血症三分位组与结局均无显著关联(P均>0.05)。

证据类型、等级与局限

  • 证据类型:两项前瞻性队列研究的汇总回顾性分析。
  • 局限:原文未报告局限性。原文结论指出这些发现需进一步研究急性冠脉综合征患者的阻塞性睡眠呼吸暂停管理策略。

对床旁实践的改变

  • 作者认为,在合并阻塞性睡眠呼吸暂停的急性冠脉综合征患者中,中度至重度夜间低氧血症与较低的心血管事件相关。
  • 作者指出,这些发现需进一步研究急性冠脉综合征患者的阻塞性睡眠呼吸暂停管理策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The relationship between OSA-related nocturnal hypoxemia and cardiovascular outcomes in patients with acute coronary syndrome (ACS) remains controversial.

RESEARCH QUESTION: Is the severity of nocturnal hypoxemia associated with cardiovascular outcomes in patients with ACS with and without OSA?

STUDY DESIGN AND METHODS: We conducted a retrospective analysis of pooled data from 2 prospective cohort studies including 2,810 patients with ACS. Patients were stratified by percentage of time with arterial oxygen saturation < 90% (TSA90) into 3 tertiles: mild, moderate, and severe nocturnal hypoxemia. The primary end point was 1-year major adverse cardiovascular and cerebrovascular events (MACCEs). Cox proportional hazards models were used for multivariable analysis.

RESULTS: Among 2,810 patients with ACS, 1,408 patients had OSA and 1,402 patients did not have OSA. In patients with OSA, those with moderate and severe hypoxemia demonstrated lower MACCE rates compared with those with mild hypoxemia (77.8 and 72.7 per 1,000 person-years, respectively, vs 120.0 per 1,000 person-years; P = .044). After multivariable adjustment, severe hypoxemia was associated with 50% lower risk of MACCE (hazard ratio [HR], 0.50; 95% CI, 0.29-0.87; P = .015) and 68% lower risk of nonfatal myocardial infarction (HR, 0.32; 95% CI, 0.12-0.86; P = .023). Moderate hypoxemia showed 79% lower all-cause mortality (HR, 0.21; 95% CI, 0.05-0.84; P = .028) and 84% lower cardiovascular death (HR, 0.16; 95% CI, 0.03-0.78; P = .024). Restricted cubic spline analysis revealed U-shaped relationships between TSA90 and outcomes in patients with OSA. Patients without OSA showed no significant associations across hypoxemia tertiles (P > .05 for all).

INTERPRETATION: Our results indicate that in patients with ACS and OSA, moderate to severe nocturnal hypoxemia is associated with reduced cardiovascular events. These findings warrant further investigation into OSA management strategies in patients with ACS.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Zheng W, Wang X, Li SY, et al. Association of Nocturnal Hypoxemia With Lower Cardiovascular Events in Patients With Acute Coronary Syndrome and OSA. Chest. 2025. PMID: 41478496. doi:10.1016/j.chest.2025.11.052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。